Compare STIM & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STIM | SCOR |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.6M | 112.4M |
| IPO Year | 2018 | 2007 |
| Metric | STIM | SCOR |
|---|---|---|
| Price | $2.02 | $7.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 14.8K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.25 | ★ 127.37 |
| EPS | N/A | ★ 4.25 |
| Revenue | $52,776,000.00 | ★ $403,549,000.00 |
| Revenue This Year | $11.10 | $2.75 |
| Revenue Next Year | $11.92 | $7.30 |
| P/E Ratio | ★ N/A | $1.74 |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $0.80 | $4.39 |
| 52 Week High | $4.84 | $10.18 |
| Indicator | STIM | SCOR |
|---|---|---|
| Relative Strength Index (RSI) | 69.40 | 48.51 |
| Support Level | $1.23 | $7.03 |
| Resistance Level | $2.13 | $8.27 |
| Average True Range (ATR) | 0.14 | 0.61 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 84.90 | 30.77 |
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.